TECH - From Years to Months: How AI is Shaping the Landscape of Clinical Trials | Benzinga

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These human studies, crucial to drug development, can take years and accrue costs in the billions.

AI's involvement in drug discovery has been experimental for years, with the hope that machines might be the key to discovering the next big pharmaceutical breakthrough. While a few AI-selected compounds are in development, their outcomes remain to be seen.

Related Content: Full story available on Benzinga.com